Cornell Vaginal Ring | The Contraceptive Pipeline Database

Product Overview

Alternative Name: BioRings Intravaginal Ring

Development Status: Active Development

Target: Female

Mode: Non-hormonal

Delivery Type: Vaginal Ring

Duration Type: Short-acting

Description: A vaginal ring that releases multiple types of non-hormonal agents and microbicides/anti-viral agents, including ferrous gluconate, ascorbic acid, pharmalytes, boclysinated betulonic acid, and tenofovir.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): tenofovir, ascorbic acid, ferrous gluconate, boclysinated betulonic acid

Inactive material: nanoporous elastomere hydrogel

Potential Multi-Purpose Technology (MPT): Yes

Regimen: once per month

Duration: 28 days

Partner: BioRings, Weill Cornell Medical College, QPharma

Status

Project Phase: Early Development

Project Stage: Pre-clinical

Programmatic Considerations

Additional Information

Additional Information:
Biorings Company Website

2015 Press Release: Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC

2009 Press Release: Cornell researchers develop anti-viral vaginal ring

Han YA, Singh M, Saxena BB. (2007) Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. Contraception. 76(2):132-8.

Download Product Report